NCT05285839RecruitingPhase 4
Dupixent and Narrowband UVB for Atopic Dermatitis
Single Center, Pilot Study to Evaluate the Effectiveness and Safety of Dupilumab in Combination With Narrowband UVB (nUVB) Phototherapy in the Treatment of Moderate-to-Severe Atopic Dermatitis
Source: ClinicalTrials.gov · Last updated 15 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
24 weeks open-label study with dupilumab and narrowband UVB phototherapy three times weekly for 12 weeks followed by 12 weeks of dupilumab monotherapy.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 8 Mar 2022
- Start date
- 19 Apr 2022
- Primary completion date
- 1 Dec 2024
- Lead sponsor
- Psoriasis Treatment Center of Central New Jersey
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT05285839
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 40
- From 19 Apr 2022 to the primary completion date, 1 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects with previous exposure to dupilumab.
Other illness
- Known or suspected hypersensitivity to dupilumab or any of its excipients.
- History of photosensitivity.
Who the study is looking for
- Male or female adult ≥ 18 years of age;
- Diagnosis of moderate to severe atopic dermatitis as defined at baseline by:
- EASI score of 16 or greater,
- IGA score of 3 or greater
- BSA of 10% or greater,
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eczema Treatment Center of New Jersey Coordinator of this site? Confirm its status | East Windsor | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.